Effects of mulberry leaf extract on blood glucose and serum lipid profiles in patients with type 2 diabetes mellitus: A systematic review

European Journal of Integrative Medicine

Volumn 8, Issue 5, 2016, Pages 602-608

  Shin, Seung Ok ^a   Seo, Hyun Ju ^b   Park, Hyunyoung ^c   Song, Hyun Jin ^d  

^a Department of Nursing   (South Korea)

^b Chosun University   (South Korea)

^c Honam University   (South Korea)

^d Sungkyunkwan University   (South Korea)

Author keywords

Blood glucose; Morus; Mulberry; Serum lipids; Systematic review; Type 2 diabetes mellitus

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; GAMMA GLUTAMYLTRANSFERASE; GLIBENCLAMIDE; GLUCOSE; GLYCOSYLATED HEMOGLOBIN; LIPID; METFORMIN; MULBERRY EXTRACT; PLACEBO;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIDIABETIC ACTIVITY; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; DATA BASE; DRUG EFFICACY; DRUG SAFETY; GAMMA GLUTAMYL TRANSFERASE BLOOD LEVEL; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; HYPERLIPIDEMIA; HYPOLIPEMIA; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OUTCOME ASSESSMENT; PLANT LEAF; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SIDE EFFECT;

EID: 84979671182     PISSN: 18763820     EISSN: 18763839     Source Type: Journal    
DOI: 10.1016/j.eujim.2016.06.008     Document Type: Review

References (51)

1. [1] International Diabetes Federation (IDF), IDF Diabetes Atlas. 7th ed., 2015, IDF, Brussels.
2. [2] Melmed, S., Polonsky, K.S., Larsen, P.R., Kronenberg, H.M., Williams Textbook of Endocrinology. 12th ed., 2012, Elsevier/Saunders, Philadelphia.
3. [3] American Diabetes Association, Economic costs of diabetes in the U. S. in 2012. Diabetes Care 36 (2013), 1033–1046.
4. [4] Lee, K.W., Costs of diabetes mellitus in Korea. J. Diabetes Metab. 35 (2011), 567–570.
5. [5] Roh, E., Ko, S.H., Kwon, H.S., Kim, N.H., Kim, J.H., Kim, C.S., Cha, B.Y., Prevalence and management of dyslipidemia in Korea: Korea National Health and Nutrition Examination Survey during 1998 to 2010. Diabetes Metab. J. 37 (2013), 433–449.
6. [6] Joseph, J.J., Golden, S.H., Type 2 diabetes and cardiovascular disease: what next?. Curr. Opin. Endocrinol. Diabetes Obes. 21 (2014), 109–120.
7. [7] Al-Khawaldeh, O.A., Al-Hassan, M.A., Froelicher, E.S., Self-efficacy self-management, and glycemic control in adults with type 2 diabetes mellitus. J. Diabetes Complications 26 (2012), 10–16.
8. [8] Korea Centers for Disease Control and Prevention (KCDCP), Korea Health Statistics 2012: Korea National Health and Nutrition Examination Survey (KNHANES V-3). 2013, KCDCP, Cheongju, Korea.
9. [9] Bolen, S., Feldman, L., Vassy, J., Wilson, L., Yeh, H.C., Marinopoulos, S., Brancati, F.L., Systematic review: comparative effectiveness and safety of oral medications for type 2 diabetes mellitus. Ann. Intern. Med. 147 (2007), 386–399.
10. [10] Meier, C., Kraenzlin, M.E., Bodmer, M., Jick, S.S., Jick, H., Meier, C.R., Use of thiazolidinediones and fracture risk. Arch. Intern. Med. 168 (2008), 820–825.
11. [11] Matheka, D.M., Alkizim, F.O., Complementary and alternative medicine for type 2 diabetes mellitus: role of medicinal herbs. J. Diabetes Endocrinol. 3 (2012), 44–56.
12. [12] Bell, R.A., Suerken, C.K., Grzywacz, J.G., Lang, W., Quandt, S.S., Arcury, T.A., Complementary and alternative medicine use among adults with diabetes in the United States. Altern. Ther. Health Med. 12 (2006), 16–22.
13. [13] Kim, H.B., kang, C.K., Sang, G.B., Kang, S.W., Lee, J.R., Anti-oxidative capacity of mulberry leaf and its tea. Korean J. Seric. Sci. 49 (2007), 18–23.
14. [14] Chau, C.F., Wu, S.H., The development of regulations of Chinese herbal medicines for both medicinal and food uses. Trends Food Sci. Technol. 17 (2006), 313–323.
15. [15] Oku, T., Yamada, M., Nakamura, M., Sadamori, N., Nakamura, S., Inhibitory effects of extractives from leaves of Morusalba on human and rat small intestinal disaccharidase activity. Br. J. Nutr. 95 (2006), 933–938.
16. [16] Moon, S.J., Baek, S.M., Park, J.H., Lee, S.H., Seo, H.J., Kim, S.G., Lee, M.H., Jeong, J.H., Choi, S.M., The use of complementary and alternative medicine in patients with type 2 diabetes mellitus: community based survey. J. Korean Orient. Intern. Med. 33 (2012), 317–326.
17. [17] Murata, K., Yatsunami, K., Fukuda, E., Onodera, S., Mizukami, O., Hoshino, G., Kamei, T., Antihyperglycemic effects of propolis mixed with mulberry leaf extract on patients with type 2 diabetes. Altern. Ther. Health Med. 10 (2004), 78–79.
18. [18] Asano, N., Oseki, K., Tomioka, E., Kizu, H., Matsui, K., N-containing sugars from Morus alba and their glycosidase inhibitory activities. Carbohydr. Res. 259 (1994), 243–255.
19. [19] Sharma, S.B., Gupta, S., Ac, R., Singh, U.R., Rajpoot, R., Shukla, S.K., Antidiabetogenic action of Morus rubra L. leaf extract in streptozotocin-induced diabetic rats. J. Pharm. Pharmacol. 62 (2010), 247–255.
20. [20] Nazari, M., Hajizadeh, M.R., Mahmoodi, M., Mirzaei, M.R., Hassanshahi, G., The regulatory impacts of Morus alba leaf extract on some enzymes involved in glucose metabolism pathways in diabetic rat liver. Clin. Lab. 59 (2012), 497–504.
21. [21] Kobayashi, Y., Miyazawa, M., Kamei, A., Abe, K., Kojima, T., Ameliorative effects of mulberry (Morus alba L.) leaves on hyperlipidemia in rats fed a high-fat diet: induction of fatty acid oxidation, inhibition of lipogenesis, and suppression of oxidative stress. Biosci. Biotechnol. Biochem. 74 (2010), 2385–2395.
22. [22] Andallu, B., Suryakantham, V., Srikanthi, B.L., Reddy, G.K., Effect of mulberry (Morus indica L.) therapy on plasma and erythrocyte membrane lipids in patients with type 2 diabetes. Clin. Chim. Acta 314 (2001), 47–53.
23. [23] Banu, S., Jabir, N.R., Manjunath, N.C., Khan, M.S., Ashraf, G.M., Kamal, M.A., Tabrez, S., Reduction of post-prandial hyperglycemia by mulberry tea in type-2 diabetes patients. Saudi J. Biol. Sci. 22 (2015), 32–36.
24. [24] Higgins, J.P., Deeks, J.J., Chapter 7: selecting studies and collecting data. Higgins, J.P.T., Green, S., (eds.) Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0, 2011, The Cochrane Collaboration.
25. [25] Ionescu-Tîrgovişte, C., Popa, E., Mirodon, Z., Simionescu, M., Mincu, I., The effect of a plant mixture on the metabolic equilibrium in patients with type-2 diabetes mellitus. Rev. Med. Int. Neurol. Psihiatr. Neurochir. Dermatovenerol. Med. Int. 41 (1988), 185–192.
26. [26] Arýkan, D., Sívríkaya, S.K., Olgun, N., Complementary alternative medicine use in children with type 1 diabetes mellitus in Erzurum Turkey. J. Clin. Nurs. 18 (2009), 2136–2144.
27. [27] Park, S., Park, J.S., Go, H., Jang, B.H., Shin, Y., Ko, S.G., The efficacy and safety study of dietary supplement PURIAM110 on non-insulin taking Korean adults in the stage of pre-diabetes and diabetes mellitus: protocol for a randomized, double-blind, placebo-controlled, and multicenter trial-pilot study. Trials, 12, 2011, 38.
28. [28] Kim, H.J., Yoon, K.H., Kang, M.J., Yim, H.W., Lee, K.S., Vuksan, V., Sung, M.K., A six-month supplementation of mulberry, Korean red ginseng, and banaba decreases biomarkers of systemic low-grade inflammation in subjects with impaired glucose tolerance and type 2 diabetes. Evid. Based Complement Altern. Med., 2012, 2012, 735191.
29. [29] Kimura, T., Nakagawa, K., Kubota, H., Kojima, Y., Goto, Y., Yamagishi, K., Miyazawa, T., Food-grade mulberry powder enriched with 1-deoxynojirimycin suppresses the elevation of postprandial blood glucose in humans. J. Agric. Food Chem. 55 (2007), 5869–5874.
30. [30] Asai, A., Nakagawa, K., Higuchi, O., Kimura, T., Kojima, Y., Kariya, J., Oikawa, S., Effect of mulberry leaf extract with enriched 1-deoxynojirimycin content on postprandial glycemic control in subjects with impaired glucose metabolism. J. Diabetes Invest. 2 (2011), 318–323.
31. [31] Yeon, K., Mok, O., Won, P., Won, K., Mulberry leaf extract improves postprandial glucose response in prediabetic subjects: a randomized double-blind placebo-controlled trial. J. Med. Food 18 (2015), 306–313.
32. [32] Riche, D.M., Krista, D., Zhong, L.T., East, H.E., Impact of mulberry leaf extract on type 2 diabetes (Mul-DM). Am. Coll. Clin. Pharm. Annu. Meet. Abstr., 2010, 391e.
33. [33] Mudra, M., Ercan-Fang, N., Zhong, L., Furne, J., Levitt, M., Influence of mulberry leaf extract on the blood glucose and breath hydrogen response to ingestion of 75 g sucrose by type 2 diabetic and control subjects. Diabetes Care 30 (2007), 1272–1274.
34. [34] Yang, J.H., Han, J.S., Effect of mulberry leaf extract supplement on blood glucose, glycated hemoglobin and serum lipids in type II diabetic patients. J. Korean Soc. Food Sci. Nutr. 35 (2006), 549–556.
35. [35] Nakamura, M., Nakamura, S., Oku, T., Suppressive response of confections containing the extractive from leaves of Morus alba on postprandial blood glucose and insulin in healthy human subjects. Nutr. Metab., 6, 2009, 29.
36. [36] Chung, H.I., Kim, J., Kim, J.Y., Kwon, O., Acute intake of mulberry leaf aqueous extract affects postprandial glucose response after maltose loading: randomized double-blind placebo-controlled pilot study. J. Funct. Foods 5 (2013), 1502–1506.
37. [37] Kimura, M., Chen, F.J., Nakashima, N., Kimura, I., Asano, N., Koya, S., Antihyperglycemic effects of N-containing sugars derived form mulberry leaves in streptozotocin induced diabetic mice. J. Tradit. Med. 12 (1995), 214–219.
38. [38] Naowaboot, J., Chung, C.H., Pannangpetch, P., Choi, R., Kim, B.H., Lee, M.Y., Kukongviriyapan, U., Mulberry leaf extract increases adiponectin in murine 3T3-L1 adipocytes. Nutr. Res. 32 (2012), 39–44.
39. [39] Aramwit, P., Petcharat, K., Supasyndh, O., Efficacy of mulberry leaf tablets in patients with mild dyslipidemia. Phytother. Res. 25 (2011), 365–369.
40. [40] Sharma, S.B., Tanwar, R.S., Rini, A.C., Singh, U.R., Gupta, S., Shukla, S.K., Protective effect of Morus rubra L. leaf extract on diet-induced atherosclerosis in diabetic rats. Indian J. Biochem. Biophys. 47 (2010), 26–31.
41. [41] Chan, K.C., Yang, M.Y., Lin, M.C., Lee, Y.J., Chang, W.C., Wang, C.J., Mulberry leaf extract inhibits the development of atherosclerosis in cholesterol-fed rabbits and in cultured aortic vascular smooth muscle cells. J. Agric. Food Chem. 61 (2013), 2780–2788.
42. [42] Mooradian, A.D., Dyslipidemia in type 2 diabetes mellitus. Nat. Clin. Pract. Endocrinol. Metab. 5 (2009), 150–159.
43. [43] Krauss, R.M., Lipids and lipoproteins in patients with type 2 diabetes. Diabetes care 27 (2004), 1496–1504.
44. [44] Nuengchamnong, N., Ingkaninan, K., Kaewruang, W., Wongareonwanakij, S., Hongthongdaeng, B., Quantitative determination of 1-deoxynojirimycin in mulberry leaves using liquid chromatography–andem mass spectrometry. J. Pharm. Biomed. Anal. 44 (2007), 853–858.
45. [45] Ministry of Agriculture, Food and Rural Affairs (MAFRA), The Development of Manufacturing Technique on Health Food with High Value Using YK-209 Mulberry Leaves. 2002, MAFRA, Korea.
46. [46] El-Beshbishy, H.A., Singab, A.N.B., Sinkkonen, J., Pihlaja, K., Hypolipidemic and antioxidant effects of Morus alba L. (Egyptian mulberry) root bark fractions supplementation in cholesterol-fed rats. Life Sci. 78 (2006), 2724–2733.
47. [47] Lee, Y.J., Choi, D.H., Kim, E.J., Kim, H.Y., Kwon, T.O., Kang, D.G., Lee, H.S., Hypotensive hypolipidemic, and vascular protective effects of Morus alba L. in rats fed an atherogenic diet. Am. J. Chin. Med. 39 (2011), 39–52.
48. [48] Hsu, L.S., Ho, H.H., Lin, M.C., Chyau, C.C., Peng, J.S., Wang, C.J., Mulberry water extracts (MWEs) ameliorated carbon tetrachloride-induced liver damages in rat. Food Chem. Toxicol. 50 (2012), 3086–3093.
49. [49] Faber, E.D., Oosting, R., Neefjes, J.J., Ploegh, H.L., Meijer, D.K., Distribution and elimination of the glycosidase inhibitors 1-deoxymannojirimycin and N-methyl-1-deoxynojirimycin in the rat in vivo. Pharm. Res. 9 (1992), 1442–1450.
50. [50] Ou, T.T., Kuo, C.Y., Chyau, C.C., Lee, H.J., Peng, J.S., Wang, C.J., Improvement of lipopolysaccharide-induced hepatic injuries and inflammation with mulberry extracts. J. Sci. Food Agric. 93 (2013), 1880–1886.
51. [51] Schulz, K.F., Altman, D.G., Moher, D., CONSORT Group: CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials. Ann. Intern. Med. 152 (2010), 726–732.